scispace - formally typeset
J

Jens J. Holst

Researcher at University of Copenhagen

Publications -  1657
Citations -  120703

Jens J. Holst is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Insulin & Glucagon. The author has an hindex of 160, co-authored 1536 publications receiving 107858 citations. Previous affiliations of Jens J. Holst include Panum Institute & Queen Elizabeth Hospital Birmingham.

Papers
More filters
Journal ArticleDOI

The Physiology of Glucagon-like Peptide 1

TL;DR: The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion, thereby contributing to limit postprandial glucose excursions and acts as an enterogastrone and part of the "ileal brake" mechanism.
Journal ArticleDOI

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

TL;DR: In mild type-2 diabetes, GLP-1 [7-36 amide], in contrast to GIP, retains much of its insulinotropic activity and lowers glucagon concentrations.
Journal ArticleDOI

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

TL;DR: Glucagon-like peptide 1 (GLP-1) could be a new treatment for type 2 diabetes, though further investigation of the long-term effects of this peptide hormone is needed.
Journal ArticleDOI

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

TL;DR: The results show that GLP-1 enhanced satiety and reduced energy intake and thus may play a physiological regulatory role in controlling appetite and energy intake in humans.